- Home
- CNO vs PTGX Comparison
CNO vs PTGX Comparison
Compare CNO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNO | PTGX |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 5.4B |
| IPO Year | 1987 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CNO | PTGX |
|---|---|---|
| Price | $40.18 | $89.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $43.60 | ★ $86.44 |
| AVG Volume (30 Days) | 604.2K | ★ 898.7K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | ★ 20.08 | N/A |
| EPS | ★ 2.98 | 0.72 |
| Revenue | ★ $4,441,500,000.00 | $209,217,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.57 | $296.47 |
| P/E Ratio | ★ $13.48 | $124.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.63 | $33.70 |
| 52 Week High | $43.20 | $93.25 |
Technical Indicators
Market Signals| Indicator | CNO | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 64.67 |
| Support Level | $40.03 | $83.52 |
| Resistance Level | $40.71 | $90.85 |
| Average True Range (ATR) | 0.80 | 2.63 |
| MACD | -0.09 | -0.33 |
| Stochastic Oscillator | 30.26 | 83.62 |
Price Performance
Historical ComparisonAbout CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.